 Neovascularization, Pathologic
"Neovascularization, Pathologic" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A pathologic process consisting in proliferation of blood vessels in abnormal tissues or in abnormal positions.
| Descriptor ID |
D009389
|
| MeSH Number(s) |
C23.550.589.500
|
| Concept/Terms |
Neovascularization, Pathologic- Neovascularization, Pathologic
- Pathologic Neovascularization
- Neovascularization, Pathological
- Pathological Neovascularization
- Pathologic Angiogenesis
- Angiogenesis, Pathologic
- Angiogenesis, Pathological
- Pathological Angiogenesis
|
Below are MeSH descriptors whose meaning is more general than "Neovascularization, Pathologic".
Below are MeSH descriptors whose meaning is more specific than "Neovascularization, Pathologic".
This graph shows the total number of publications written about "Neovascularization, Pathologic" by people in this website by year, and whether "Neovascularization, Pathologic" was a major or minor topic of these publications.
To see the data from this visualization as text, click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1992 | 1 | 0 | 1 | | 1993 | 0 | 1 | 1 | | 1994 | 1 | 0 | 1 | | 1995 | 0 | 1 | 1 | | 1996 | 2 | 1 | 3 | | 1997 | 1 | 0 | 1 | | 1998 | 4 | 0 | 4 | | 1999 | 1 | 0 | 1 | | 2000 | 0 | 1 | 1 | | 2001 | 2 | 0 | 2 | | 2002 | 0 | 4 | 4 | | 2003 | 1 | 3 | 4 | | 2004 | 0 | 2 | 2 | | 2005 | 0 | 6 | 6 | | 2006 | 2 | 2 | 4 | | 2007 | 1 | 1 | 2 | | 2008 | 1 | 6 | 7 | | 2009 | 3 | 3 | 6 | | 2010 | 1 | 4 | 5 | | 2011 | 4 | 9 | 13 | | 2012 | 3 | 1 | 4 | | 2013 | 1 | 2 | 3 | | 2014 | 1 | 2 | 3 | | 2015 | 2 | 1 | 3 | | 2016 | 0 | 1 | 1 |
To return to the timeline, click here.
Below are the most recent publications written about "Neovascularization, Pathologic" by people in Profiles.
-
Rajeshkumar NV, Yabuuchi S, Pai SG, Tong Z, Hou S, Bateman S, Pierce DW, Heise C, Von Hoff DD, Maitra A, Hidalgo M. Superior therapeutic efficacy of nab-paclitaxel over cremophor-based paclitaxel in locally advanced and metastatic models of human pancreatic cancer. Br J Cancer. 2016 08 09; 115(4):442-53.
-
Duquette M, Sadow PM, Husain A, Sims JN, Antonello ZA, Fischer AH, Song C, Castellanos-Rizaldos E, Makrigiorgos GM, Kurebayashi J, Nose V, Van Hummelen P, Bronson RT, Vinco M, Giordano TJ, Dias-Santagata D, Pandolfi PP, Nucera C. Metastasis-associated MCL1 and P16 copy number alterations dictate resistance to vemurafenib in a BRAFV600E patient-derived papillary thyroid carcinoma preclinical model. Oncotarget. 2015 Dec 15; 6(40):42445-67.
-
Shao R, Taylor SL, Oh DS, Schwartz LM. Vascular heterogeneity and targeting: the role of YKL-40 in glioblastoma vascularization. Oncotarget. 2015 Dec 01; 6(38):40507-18.
-
Cataltepe S, Arikan MC, Liang X, Smith TW, Cataltepe O. Fatty acid binding protein 4 expression in cerebral vascular malformations: implications for vascular remodelling. Neuropathol Appl Neurobiol. 2015 Aug; 41(5):646-56.
-
Niu G, Ye T, Qin L, Bourbon PM, Chang C, Zhao S, Li Y, Zhou L, Cui P, Rabinovitz I, Mercurio AM, Zhao D, Zeng H. Orphan nuclear receptor TR3/Nur77 improves wound healing by upregulating the expression of integrin ß4. FASEB J. 2015 Jan; 29(1):131-40.
-
Song G, Darr DB, Santos CM, Ross M, Valdivia A, Jordan JL, Midkiff BR, Cohen S, Nikolaishvili-Feinberg N, Miller CR, Tarrant TK, Rogers AB, Dudley AC, Perou CM, Zamboni WC. Effects of tumor microenvironment heterogeneity on nanoparticle disposition and efficacy in breast cancer tumor models. Clin Cancer Res. 2014 Dec 1; 20(23):6083-95.
-
Mittal K, Ebos J, Rini B. Angiogenesis and the tumor microenvironment: vascular endothelial growth factor and beyond. Semin Oncol. 2014 Apr; 41(2):235-51.
-
McCready J, Arendt LM, Glover E, Iyer V, Briendel JL, Lyle SR, Naber SP, Jay DG, Kuperwasser C. Pregnancy-associated breast cancers are driven by differences in adipose stromal cells present during lactation. Breast Cancer Res. 2014 Jan 09; 16(1):R2.
-
Shao R, Francescone R, Ngernyuang N, Bentley B, Taylor SL, Moral L, Yan W. Anti-YKL-40 antibody and ionizing irradiation synergistically inhibit tumor vascularization and malignancy in glioblastoma. Carcinogenesis. 2014 Feb; 35(2):373-82.
-
Zhang CX, He HW, Shao RG. [Sphingosine kinase 1 and tumor]. Yao Xue Xue Bao. 2013 Jul; 48(7):971-8.
|
People  People who have written about this concept. _
Similar Concepts
People who have written about this concept.
_
Top Journals
Top journals in which articles about this concept have been published.
|